SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-22-011571
Filing Date
2022-04-29
Accepted
2022-04-29 16:26:30
Documents
3

Document Format Files

Seq Description Document Type Size
1 defa14a.htm DEFA14A 13687
2 defa14a_001.jpg GRAPHIC 447988
3 defa14a_002.jpg GRAPHIC 188351
  Complete submission text file 0001493152-22-011571.txt   890859
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-12830 | Film No.: 22876015
SIC: 2836 Biological Products, (No Diagnostic Substances)